← FDA Drug Approvals (Drugs@FDA)

PROPOFOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2024-06-20

Drug application

FDA Application #

ANDA217013

Application type

Abbreviated New Drug Application (Generic)

Brand name

PROPOFOL

Generic name

Propofol

Active ingredients

PROPOFOL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ASPIRO

First approval

2024-06-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown